Uncategorized

Find the Money Before the Patent Dies: How to Identify Out-Licensing Targets Near Drug Patent Expiry — and Capture Value That Most Companies Leave on the Table

Most companies don’t miss patent expiry—they miss the money that appears before it.
Drug patent expiry is treated like a cliff: once the clock hits zero, generic and biosimilar competition arrives, margins compress, and the industry scrambles. But the …

Find the Money Before the Patent Dies: How to Identify Out-Licensing Targets Near Drug Patent Expiry — and Capture Value That Most Companies Leave on the Table Read Post »

Biotechblog
Scroll to Top